Voyager Therapeutics, Inc.
VYGR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27,892 | -$33,382 | -$31,021 | -$34,487 |
| Dep. & Amort. | $932 | -$724 | $1,014 | $1,011 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $4,133 | $3,673 | $3,737 |
| Change in WC | -$8,127 | -$5,490 | -$11,814 | $16,691 |
| Other Non-Cash | $4,039 | $2,202 | $253 | -$1,481 |
| Operating Cash Flow | -$31,048 | -$33,261 | -$37,895 | -$14,529 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$207 | -$1,105 | -$658 | -$155 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$6,636 | -$37,866 | -$76,924 | -$131,018 |
| Inv. Sales/Matur. | $41,731 | $40,904 | $118,783 | $103,970 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $34,888 | $1,933 | $41,201 | -$27,203 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $85 | $513 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $82 | $574 |
| Financing Cash Flow | $85 | $513 | $82 | $574 |
| Forex Effect | -$2,740 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,185 | -$30,815 | $3,388 | -$41,158 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $43,940 | $77,629 | $74,241 | $115,399 |
| End Cash | $45,125 | $46,814 | $77,629 | $74,241 |
| Free Cash Flow | -$31,255 | -$34,366 | -$38,553 | -$14,684 |